Stay updated on Masitinib Efficacy and Safety in ALS Clinical Trial
Sign up to get notified when there's something new on the Masitinib Efficacy and Safety in ALS Clinical Trial page.

Latest updates to the Masitinib Efficacy and Safety in ALS Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page’s revision tag was updated from Revision: v3.6.2 to Revision: v3.6.3, signaling a newer release of the page. This is a small, meta-level change and does not alter the study content or user-facing information.SummaryDifference0.0%

- Check17 days agoChange DetectedThe page revision is updated from v3.6.0 to v3.6.2, indicating a newer page version. This change reflects a backend or template update rather than changes to the study details.SummaryDifference0.0%

- Check31 days agoChange DetectedNew quick-access links were added (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label formatting was standardized from 'Intervention / Treatment' to 'Intervention/Treatment'. The revision tag was updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check38 days agoChange DetectedThe page now shows revision v3.5.5, replacing the previous v3.5.4, indicating an administrative update to the ClinicalTrials.gov record. This update does not alter substantive content such as study design or results.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a newer build of the ClinicalTrials.gov record. This change reflects maintenance or metadata updates rather than modifications to study details.SummaryDifference0.0%

- Check66 days agoChange DetectedA new entry for Malmö, Sweden has been added to the study's locations, and the previous Malmo, Sweden entry has been removed.SummaryDifference0.0%

Stay in the know with updates to Masitinib Efficacy and Safety in ALS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Masitinib Efficacy and Safety in ALS Clinical Trial page.